Ipamorelin – 5mg

Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue receptor (GHS-R1a) agonist, the most receptor selective GHRP in the research literature, distinguished from GHRP-2, GHRP-6, and Hexarelin by its highly targeted activity profile that produces GH secretion with minimal influence on cortisol, prolactin, ACTH, or aldosterone. Hudson Science’s 5mg lyophilized vial delivers a lower concentration presentation than the iLab Pharma 10mg Ipamorelin vial. Suited to researchers initiating Ipamorelin protocols, conducting dose response characterization at conservative concentration points, or requiring a supply volume matched to shorter duration research timelines.

The 5mg and 10mg Ipamorelin vials serve distinct research procurement purposes within CSD’s Ipamorelin range. The 5mg Hudson Science format provides the lowest standalone concentration entry point; particularly relevant for protocols beginning at conservative GHS-R1a activation levels before dose escalation, or for combination research with CJC-1295 where the CJC-IPA Blend is unavailable and individual compound ratio control is required. The 10mg iLab Pharma format suits extended protocols and multi group designs requiring greater compound availability per vial. Both are also available as the pre combined Hudson Science CJC-IPA Blend for researchers preferring standardized co administration over individual compound sourcing.

Ipamorelin’s exceptional GHS-R1a selectivity, producing GH release with documented minimal cortisol, prolactin, and ACTH effects. Makes it the preferred GHRP reference compound for research specifically isolating pituitary somatotroph GHS-R1a activation from secondary hormonal variables. CSD’s complete GHRP range covers four distinct selectivity and potency profiles. Ipamorelin’s clean selectivity, GHRP-2’s superior potency with moderate secondary hormonal effects, GHRP-6’s pronounced appetite stimulation through ghrelin pathway activation, and Hexarelin’s maximum GH potency with additional CD36 cardiac receptor activity giving researchers access to the full GHS-R1a agonist spectrum from a single verified Canadian supplier.

Hudson Science formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and Hudson Science’s Ipamorelin meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Reconstitute with bacteriostatic water prior to use. Store lyophilized peptide at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.

Commonly researched alongside CJC-1295 and Tesamorelin in comparative GH secretagogue combination and GHS-R1a selectivity studies. Browse CSD’s full peptide range for complete sourcing.